Market Overview

Albemarle's Sale Of Surface Treatment Unit 'Furthers Compelling Lithium Growth Story'

Related ALB
War-Torn Afghanistan Sits Stubbornly Atop Vast Reserves Of Battery-Grade Lithium
15 Biggest Mid-Day Losers For Monday

Shares of Albemarle Corporation (NYSE: ALB) have traded up nearly 4 percent since the company announced on Friday a deal to sell its Surface Treatment unti to BASF for $3.2 billion.

Deutsche Bank's David Begleiter voiced his praise for the deal and, in a research note Monday, said, the Surface Treatment "sale furthers the (compelling) lithium growth story."

The analyst reiterated a Buy rating and boosted his price target on shares of Albemarle from $84 to $94.

"Albemarle has taken an important step toward its goal of becoming a focused, high growth, high margin lithium and catalyst company," according to Begleiter.

He also noted three other positives to the deal:

  • "delevers the balance sheet to its targeted 2.0-2.5x net debt/EBITDA, thus removing a key investor concern,
  • provides funding for the company's $600MM lithium capacity expansion and
  • enables material ($1B-plus) share buybacks in ’17-’18."

Latest Ratings for ALB

Mar 2017CitigroupDowngradesBuyNeutral
Feb 2017RBC CapitalInitiates Coverage OnOutperform
Jan 2017BairdUpgradesNeutralOutperform

View More Analyst Ratings for ALB
View the Latest Analyst Ratings

Posted-In: David Begleiter Deutsche BankAnalyst Color News Price Target Reiteration Asset Sales Analyst Ratings


Related Articles (ALB)

View Comments and Join the Discussion!